OVERVIEW OF BIOCHEMICAL PHARMACOLOGY OF PROBUCOL

被引：48

作者：

BARNHART, JW ^{[1
]}

RYTTER, DJ ^{[1
]}

MOLELLO, JA ^{[1
]}

机构：

[1] DOW CHEM USA,DEPT HLTH & CONSUMER PROD,INDIANAPOLIS,IN 46268

来源：

LIPIDS | 1977年 / 12卷 / 01期

关键词：

D O I：

10.1007/BF02532968

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：29 / 33

页数：5

相关论文

共 22 条

[1] AMADOR E, 1963, CLIN CHEM, V9, P391
[2] BARNHART JW, 1970, AM J CLIN NUTR, V23, P1229
[3] BONNICHSEN R, METHODS ENZYMOLOGY, V2, P781
[4] CARROLL NV, 1956, J BIOL CHEM, V220, P583
[5] EFFECT OF [4,4'-(ISOPROPYLIDENEDITHIO)BIS(2,6-DI-T-BUTYLPHENOL)] (DH-581) ON SERUM LIPIDS AND LIPOPROTEINS IN HUMAN SUBJECTS
DRAKE, JW
BRADFORD, RH
MCDEARMON, M
FURMAN, RH
[J]. METABOLISM, 1969, 18 (11): : 916 - +
[6] GRUNDY SM, 1965, J LIPID RES, V6, P397
[7] LONG-TERM ORAL-ADMINISTRATION OF PROBUCOL [4,4'-(ISOPROPYLIDENEDITHIO)BIS (2,6-DI-T-BUTYLPHENOL)] (DH-581) IN MANAGEMENT OF HYPERCHOLESTEROLEMIA
HARRIS, RS
GILMORE, HR
BRICKER, LA
KIEM, IM
RUBIN, E
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1974, 22 (04) : 167 - 175
[8] HENLY AA, 1957, ANALYST, V82, P286
[9] KING J, 1960, J Med Lab Technol, V17, P1
[10] KRITCHEVSKY D, 1971, P SOC EXP BIOL MED, V136, P1216